Translation of basic research into useful treatments: How often does it occur?

American Journal of Medicine

Volumn 114, Issue 6, 2003, Pages 503-505

  Crowley Jr , William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; PROTEIN KINASE;

ALGORITHM; ARTICLE; BIOINFORMATICS; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG DEVELOPMENT; DRUG INDUSTRY; EDUCATION PROGRAM; FOLLOW UP; GENOME; HEALTH CARE; HEALTH CENTER; HUMAN; INFORMATION RETRIEVAL; LEUKEMIA; LINGUISTICS; MEDICAL EDUCATION; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MOLECULAR CLONING; MULTIFACTORIAL INHERITANCE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; TEACHING HOSPITAL;

EID: 0037447532     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00119-0     Document Type: Editorial

References (13)

1. Contopoulos-Ioannidis D.G., Ntzani E.E., Ioannidis J.P.A. Translation of highly promising basic science research into clinical applications. Am J Med. 114:2003;477-484.
2. Goeddel D.V., Heyneker H.L., Hozumi T., et al. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature. 281:1979;544-548.
3. Goeddel D.V., Leung D.W., Dull T.J., et al. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature. 290:1981;20-26.
4. Goeddel DV, Ylverton E, Ullrich A, et al. Human leukocyte interferon produced by E. coli is biologically active. 1980;287:411-441.
5. Druker B.J., Talpaz M., Resta D., et al. Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 344:2001;1031-1037.
6. Druker B.J., Sawyers C.L., Kantarjian H., et al. Activity of a specific inhibitor of the Bcr-Abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 344:2001;1038-1042.
7. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 348:1996;1535-1541.
8. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Recombinant human PTH (1-34) fragment [rhPTH] reduces the risk of spine and non-spine fractures in post-menopausal osteoporosis. N Engl J Med. 344:2001;1434-1441.
9. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
10. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
11. Kelley W.N., Randolph M.A. Careers in Clinical Research Obstacles and Opportunities . 1994;National Academy Press, Washington, DC.
12. Sung N.S., Crowley W.F. Jr, Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA. 289:2003;1278-1287.
13. Nathan D.G. Careers in translational clinical research - historical perspectives, future challenges. JAMA. 287:2002;2424-2427.